DOTmed December 11, 2023
John R. Fischer

British AI company Bering Limited has nabbed 510(k)-clearance for its AI-powered chest X-ray triage solution, BraveCX, which is designed to identify pleural effusion, pneumothorax and other life-threatening conditions from chest X-rays in patients and triage and prioritize cases based on criticality.

The radiology-based computer-assisted triage and notification software is trained on over one million chest X-rays captured in different clinical settings. Bering added another 50,000 scans labeled by board-certified radiologists to further improve its accuracy and ensure the algorithm’s performance aligns with expert radiologist interpretations.

Bering says it is meant to provide a “second opinion” to physicians to help them make clinical decisions quicker and reduce time-to-diagnosis in urgent cases.

“FDA clearance means BraveCX prioritizes patient safety, whilst still delivering...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Provider, Radiology, Technology
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices

Share This Article